Author:
Konieczka Katarzyna,Koch Simone,Binggeli Tatjana,Schoetzau Andreas,Kesselring Juerg
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry, medical,Health Policy,Drug Discovery
Reference51 articles.
1. Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis—a quiet revolution. Nat Rev Neurol. 2015;11(3):134–42.
2. Dorr J, Paul F. The transition from first-line to second-line therapy in multiple sclerosis. Curr Treat Options Neurol. 2015;17(6):354.
3. Kesselring J. History of multiple sclerosis. In: Raine C, McFarland HF, Hohlfeld R, editors. Multiple sclerosis—a comprehensive text. Chapter 1. Edinburgh, London, New York, Oxford, Philadelphia, St. Louis, Sydney, Toronto: Saunders Elsevier; Crown House Pub. Ltd.; 2008. p. 1–9.
4. Dake MD, Zivadinov R, Haacke EM. Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective. Funct Neurol. 2011;26(4):181–95.
5. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010;9(7):727–39.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献